Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: J Subst Use Addict Treat. 2023 Dec 5;157:209235. doi: 10.1016/j.josat.2023.209235

Table 1.

Sample Demographic and Clinical Characteristics (n = 18)

Characteristic N (%) or Mean (SD)

Age, years 55 (8)
Gender
  Woman 10 (56%)
Race/Ethnicity
  Black 6 (33%)
  Latinx 10 (56% )
  White 2 (11%)
Insurance coverage
  Medicaid 17 (94%)
  Uninsured 1 (6%)
Education, high school equivalent or higher 9 (50%)
Current housing status
 Private residence 11 (61%)
 Temporary housing (e.g., with family or friends) 3 (17%)
 Shelter 2 (11%)
 Living on the street 1 (6%)
 Other 1 (6%)
Employment status
 Disability 7 (39%)
 Employed 6 (33%)
 Unemployed 5 (28%)
Time in methadone treatment, years 8 (6)
Methadone dose, mg/day 100 (57)
Methadone administration schedule at OTP
Prior to COVID-19
  6-days weekly 7 (39%)
  5-days weekly 5 (28%)
  4-days weekly 4 (22%)
  3-days weekly 2 (11%)
At time of interview
  3-days weekly 3 (17%)
  2-days weekly 2 (11%)
  1-day weekly 7 (39%)
  Every two weeks 6 (3%)